Company Filing History:
Years Active: 2002
Title: **Ana Beatriz Perez Diaz: Pioneering Research in Dengue Virus Immunology**
Introduction
Ana Beatriz Perez Diaz, an innovative inventor based in Habana, Cuba, has made significant contributions to the field of immunology. His research on the dengue virus has led to the development of a unique patent, showcasing the intersection of synthetic biology and disease prevention.
Latest Patents
Ana Beatriz Perez Diaz holds a patent titled "Pre-M/M epitopes of dengue virus, synthetic peptides, chimeric proteins and their use." This groundbreaking invention involves five synthetic peptides derived from the pre-M/M protein of the Dengue-2 virus, specifically corresponding to amino acid sequences 3-31, 45-67, 57-92, 69-93, and 103-124. The research outlined in the patent demonstrates that these peptides can elicit an immune response, producing neutralizing antibodies against all four serotypes of the dengue virus.
Career Highlights
Throughout his career, Ana Beatriz has focused on the immunological aspects of viral diseases, particularly dengue. His innovative research has provided insights into the anti-peptide immune response using mice as a model organism. The inventive nature of his work underscores the potential for developing effective vaccines against the dengue virus, influencing both academic and clinical research.
Collaborations
Ana Beatriz has collaborated with esteemed colleagues in the field, including Susana Vazquez Ramudo and Guadalupe Guzman Tirado. Their teamwork has enhanced the research outcomes and broadened the scope of investigations into dengue virus immunology. Together, they have made strides in developing recombinant fusion proteins that include segments of the pre-M/M protein, showcasing the collaborative spirit that drives scientific advancement.
Conclusion
Ana Beatriz Perez Diaz is a notable inventor whose research on synthetic peptides and immune responses has the potential to reshape dengue virus treatment and prevention. His patent not only reflects his innovative spirit but also contributes valuable knowledge to the scientific community, paving the way for further explorations in immunological research and public health initiatives.